BioAegis Therapeutics, Inc. — Form D

BioAegis Therapeutics, Inc. of Morristown, NJ, a company, filed a Form D exempt-offering notice with the SEC on 2016-03-14. The offering totals $5.0M, of which $1.5M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (17)

NameRoleLocation
Steven CordovanoExecutive OfficerNorth Brunswick, NJ
Valerie CevaDirectorMorristown, NJ
Valerie CevaExecutive OfficerMorristown, NJ
Mark DiNubileDirectorMorristown, NJ
Mark DiNubileExecutive OfficerMorristown, NJ
Susan LevinsonDirectorMorristown, NJ
Susan LevinsonExecutive OfficerMorristown, NJ
John StosselDirectorMorristown, NJ
Thomas StosselDirectorNorth Brunswick, NJ
Thomas StosselExecutive OfficerNorth Brunswick, NJ
Steve CordovanoExecutive OfficerMorristown, NJ
Susan L LevinsonDirectorMorristown, NJ
Susan L LevinsonExecutive OfficerMorristown, NJ
Valerie L CevaDirectorNew York, NY
Valerie L CevaExecutive OfficerNew York, NY
Thomas L StosselDirectorBelmont, MA
Steven L CordovanoExecutive OfficerRowayton, CT

Other filings by this issuer (8)

FiledFormOfferingSold
2022-05-11D$21.8M$21.8M
2020-10-07D/A$7.0M$7.0M
2020-06-17D$5.0M$5.0M
2018-09-26D$7.0M$4.1M
2015-04-17D/A$8.0M
2014-02-07D/A$6.0M$3.7M
2013-02-08D/A$6.0M$3.1M
2012-04-11D$6.0M$497K

More